Thermo Fisher completes Mesa Biotech acquisition

LabPulse.com staff writers
Feb 25, 2021
2019 11 08 01 30 1068 Thermo Fisher Amp 2019 V3 400

Thermo Fisher Scientific has completed its previously announced acquisition of point-of-care molecular diagnostics provider Mesa Biotech.

Mesa Biotech is known for its Accula system, a point-of-care polymerase chain reaction (PCR)-based testing platform for infectious disease diagnosis. Besides COVID-19, Accula also tests for influenza, respiratory syncytial virus (RSV), and group A Streptococcus.

Mesa Biotech will become part of Thermo Fisher's Life Sciences Solutions segment and is expected to add approximately $200 million in revenue this year, Thermo Fisher said.

Latest in Group A Streptococcus
Licensed under Creative Commons
Global research network launches to fight strep A infections
February 27, 2024
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
2020 08 25 20 54 0512 Test Tubes Rd Lab 400
FDA clears Mesa Biotech's point-of-care strep A test
December 8, 2020
2020 03 18 22 45 6099 2020 03 19 Genital Pathology 20200318221617
Pathologists advance understanding of deadly female genital tract infections
March 18, 2020
Related Stories
Business Handshake Man Social
Agreement
Shineco moves into point-of-care testing, inks stock purchase agreement with Chinese biotech
2020 05 01 20 07 6840 Warning Circular 400
PCR
Mesa recalls SARS-CoV-2 tests due to contamination
2020 05 07 22 15 9104 Thermo Fisher Scientific 400
Collaboration
Thermo Fisher expands leadership team
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Group A Streptococcus
Global research network launches to fight strep A infections
By Matt Limb
Scientists have launched a global research network to combat deadly strep A infections that can trigger sepsis and heart damage in children.
February 27, 2024
Licensed under Creative Commons
Hologic acquires Diagenode for $159 million
By LabPulse.com staff writers
Diagenode offers clients more than 30 polymerase chain reaction (PCR) tests, as well as a portfolio of devices, kits, reagents, and antibodies for DNA and RNA analysis.
February 28, 2021
2019 02 01 17 54 2200 Hologic Rsna 2018 400
FDA clears Mesa Biotech's point-of-care strep A test
By LabPulse.com staff writers
The strep A cassette detects group A Streptococcus bacterial nucleic acid by rapid polymerase chain reaction (PCR). It is approved for use in diagnosing children and adults and provides laboratory quality results within 30 minutes at the point of care.
December 8, 2020
2020 08 25 20 54 0512 Test Tubes Rd Lab 400
Pathologists advance understanding of deadly female genital tract infections
By Emily Hayes
Group A strep is typically found in the mouth, but it can also infect other mucosal areas of the body, with deadly results. The researchers noted that GAS surface proteins cause an estimated 700 million human infections annually around the world, including 15 million in the U.S. GAS is at the root of puerperal sepsis (also known as childbed fever), which is the leading cause of maternal deaths, and it causes necrotizing myometritis (inflammation of the uterine myometrium) as well as severe infections in newborns.
March 18, 2020
2020 03 18 22 45 6099 2020 03 19 Genital Pathology 20200318221617
Luminex MRSA test clears FDA
By LabPulse.com staff writers
The Aries MRSA assay tests directly for MRSA DNA from nasal swabs in patients at risk for nasal colonization. Clearance was granted on September 25 and announced by the company on October 1.
September 30, 2019
2019 08 20 21 21 4020 Luminex Aacc 2019 400
NeuMoDx launches 4 new CE-IVD tests
By LabPulse.com staff writers
The assays work with the company's NeuMoDx 96 and NeuMoDx 288 molecular systems.
June 25, 2019
2019 06 26 20 22 6835 Hepatitis Virus 400
Page 1 of 1